Kuwait’s Largest Law Firm Signs Collaboration Agreement with Andersen Global
Andersen Global announced today that it has signed a collaboration agreement with Kuwait’s largest law firm, Al Khebra. The addition of Al Khebra marks the 50th country with a legal services practice among the member and collaborating firms of Andersen Global. Andersen Global has nearly 400 professionals in 10 countries and more than 20 locations in the Middle East region.
Al Khebra, based in Kuwait City, is led by its Founder and Managing Partner Osama A Al-Abdul Jaleel. Al Khebra’s nearly 50 legal and tax professionals and five partners provide numerous legal services throughout the Middle East. The firm’s legal practice areas include corporate and commercial, M&A, private equity, partnerships, tax, banking and finance, real estate, venture capital, investments, restructuring, and employment.
“We are looking toward the future as a wide canvas for the endless possibilities for our firm to grow and to lead in the region. Collaborating with the Andersen Global team, our clients can be assured we will continue to provide the most seamless, professional, and innovative legal and commercial solutions,” said Osama.
“The Middle East has significant growth opportunities and is incredibly exciting for us and our expansion,” said Mark Vorsatz, Andersen Global Chairman and CEO of Andersen. “Adding a firm of the quality and scale of Al Khebra helps to continue to position Andersen Global as ‘best in class’ consistently - in every region around the globe.”
Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 4,500 professionals worldwide and a presence in over 149 locations through its member firms and collaborating firms.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190910005053/en/
Contact information
Megan Tsuei
Andersen Global
415-764-2700
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Leading Consumer Brands Ariel, Pantene and Fairy Accelerate Journey to Deliver P&G’s Ambition 203017.2.2020 07:00:00 EET | Press release
Today the Procter & Gamble Company (NYSE:PG) announced significant advances across European sustainability projects in pursuit of its “Ambition 2030” goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200216005020/en/ Ariel (Photo: Business Wire) P&G is driving the circular economy for recycled plastic in Europe through the use of circular resin in its hair care packaging (polyethylene terephthalate - PET) and its Ariel Liquid detergents bottles (partnership for the supply of recycled high-density polyethylene - HDPE). Furthermore, the company is celebrating notable distinctions in its effort to lead the industry in packaging, sorting, and post-consumer recycled resin supply with the HolyGrail intelligent packaging project, winner of both the Circular Economy innovation of the year category in the Edie Sustainability Awards in the UK, and the 1000 Efficient Solutions Label by the Solar Impulse Foundation. Lenor, Unstoppab
Shekel Brings World’s First Micro-Market to EuroShop 202016.2.2020 11:15:00 EET | Press release
Shekel Brainweigh Ltd. (ASX: SBW) and Hitachi today unveiled Capsule, the world’s first framework for a cost-effective autonomous micro-market solution based on Hitachi’s LiDAR sensors and Shekel’s Product Aware Shelves at EuroShop 2020. The first Capsule store is expected to launch in Europe in Q2 2020 and is on display at Shekel’s booth #D86 at Hall 3. “Micro-markets are the fastest growing segment of convenience shopping. We see them exploding in high traffic areas, such as workplaces, campuses, train stations and airports,” said Hideki Hayashi, Sales and Marketing Manager, Hitachi EU Ltd. “Deploying the joint Shekel-Hitachi solution enables retailers and micro-market operators to provide the 24/7 frictionless shopping experience consumers demand without sacrificing accuracy, performance or profitability.” In a recent consumer survey commissioned by Shekel, 41 percent of respondents specified that if they could return items and purchase more than one item at a time, they would be mo
Designer Outlet Croatia Builds Footfall With a New Hybrid Retail Destination and Shopper Traffic Counting Solution16.2.2020 10:00:00 EET | Press release
Johnson Controls announced that Sensormatic Solutions, its leading global retail solutions portfolio, will feature its ShopperTrak visitor analytics and shopper insights in Designer Outlet Croatia. Majority-owned by Ingka Centres, the retailer has enhanced shopper traffic performance by adding an aspirational, ‘hybrid’ retail destination to the existing IKEA Store in Zagreb. The IKEA store in Zagreb opened in August 2014 and attracts 1.5m visitors annually. Boasting 38,000 sqm of retail space, it is one of the biggest IKEA-owned sites in Europe. To drive ambient footfall and encourage more store visits to the IKEA Zagreb store, Ingka Centres group (previously known as IKEA Centres) and ROS Retail Outlet Shopping, strategically opened an adjoining designer outlet centre, Designer Outlet Croatia, in June 2018. Covering 15.000 sqm of retail space, the outlet centre contains 74 stores of discounted luxury clothing brands, including Tommy Hilfiger, Calvin Klein, Guess, and adidas. It also o
Celltrion Healthcare showcases positive 1-year results for novel subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis presented at The European Crohn's and Colitis Organisation (ECCO) annual congress14.2.2020 18:04:00 EET | Press release
Celltrion Healthcare today announced new 1-year data from a randomised controlled trial to evaluate the pharmacokinetics (PK), efficacy and safety of CT-P13 subcutaneous (SC) formulation compared to the CT-P13 intravenous (IV) formulation in patients with active Crohn’s disease (CD) and ulcerative colitis (UC). Results presented at The European Crohn's and Colitis Organisation (ECCO) 2020 annual congress in Vienna, Austria demonstrated that the SC formulation of CT-P13 was comparable to the IV formulation of CT-P13 in terms of efficacy and safety throughout the 1-year treatment period.1 In the study, 131 patients were randomised at the maintenance phase (66 to the SC arm and 65 to the IV arm), of whom 105 (80.2%) patients completed the week 54 visit (55 in the SC arm and 50 in the IV arm). After loading doses of IV 5mg/kg at weeks 0 and 2, patients were randomised at week 6 to receive either SC 120 mg (<80kg) or 240 mg (≥80 kg) every 2 weeks in the SC arm, or continued on IV 5 mg/kg ev
Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn’s Disease14.2.2020 17:37:00 EET | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from the phase 3 VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation of the gut-selective biologic vedolizumab (Entyvio®) for use during maintenance therapy in adult patients with moderately to severely active Crohn's disease (CD). The study evaluated patients who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous (IV) induction therapy at weeks 0 and 2.1 The results show that at week 52, significantly more patients on vedolizumab SC compared to placebo were in clinical remission (48.0% [n=132/275] vs. 34.3% [n=46/134] respectively; [p=0.008]),** meeting the study’s primary endpoint.1 These data were announced during an oral presentation at the 15th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Vienna, Austria. “The VISIBLE 2 study showed that the investigational subcut
Mary Kay Participates in 2020 Generational Dermatology Palm Springs Symposium14.2.2020 16:50:00 EET | Press release
Mary Kay Inc., a global beauty company and leader in skin care innovation, continued its decades-long support of the beauty and scientific communities by recently supporting the 2020 Generational Dermatology Palm Springs Symposium from Feb. 14 – 16. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200214005108/en/ Dr. Lucy Gildea, Chief Scientific Officer of Mary Kay Inc. (Photo: Mary Kay Inc.) Generational Dermatology, founded by Dr. Wendy E. Roberts, takes a multi-decade approach to the evolving aging patient, including medical, surgical and aesthetic dermatology. This symposium is targeted toward dermatologists and other core specialists at all stages of their careers. Participants join extraordinary faculty and key opinion leaders at the Omni Rancho Las Palmas, Rancho Mirage. “Our commitment to skin care science isn’t just about making new Mary Kay products,” said Dr. Lucy Gildea, Chief Scientific Officer at Mary Kay. ”Our
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom